Columbia Care Executive and Leadership Team

N.P. Narvekar, the President & Chief Executive Officer at Columbia Care, directs the overarching corporate strategy for this multi-state medical cannabis provider. Overseeing long-term growth initiatives, the President & Chief Executive Officer aligns manufacturing capabilities with evolving pharmaceutical regulations across North American markets. This leadership role involves constant engagement with the Board to ensure capital efficiency and market expansion. By prioritizing product quality and patient safety, N.P. Narvekar drives the organization toward sustainable industry leadership. The President & Chief Executive Officer manages high-level partnerships and regulatory compliance frameworks to solidify the company's position as a premier manufacturer. Through disciplined resource allocation, Narvekar fosters a culture of excellence that supports the broader mission of providing reliable cannabis-based therapeutic solutions to patients nationwide. Strategic decision-making remains the primary focus for Narvekar while navigating complex legal landscapes.

Solenie Tesfaye, the Chief Financial Officer at Columbia Care, manages all fiscal operations and financial reporting for the enterprise. Overseeing the company's capital structure, the Chief Financial Officer ensures transparency and accuracy in all accounting practices. This leadership role involves directing budget planning and forecasting to support the expansion of medical cannabis manufacturing facilities. Solenie Tesfaye works closely with the executive team to monitor cash flow and optimize operational expenditures across multiple states. By implementing robust financial controls, the Chief Financial Officer mitigates risk and enhances profitability. Tesfaye also leads investor relations efforts, communicating the company's financial health and growth trajectory to stakeholders. Through meticulous analysis of market data, the Chief Financial Officer identifies opportunities for cost reduction and revenue enhancement. Tesfaye maintains a focus on long-term fiscal sustainability, ensuring that Columbia Care possesses the necessary resources to achieve its strategic objectives.

David Hart, the Chief Operating Officer at Columbia Care, directs the daily manufacturing and supply chain logistics for the organization. Overseeing production efficiency, the Chief Operating Officer ensures that all cannabis products meet strict pharmaceutical standards before reaching patients. This leadership role involves managing cross-functional teams to streamline cultivation and distribution processes across the company's regional footprint. David Hart coordinates with facility managers to optimize output and maintain consistent quality control protocols. By integrating advanced technology into manufacturing workflows, the Chief Operating Officer drives operational excellence and reduces waste. Hart also collaborates with the executive team to align production capacity with market demand. Through continuous process improvement, the Chief Operating Officer supports the company's mission to provide reliable medical solutions. David Hart remains dedicated to scaling operations effectively, ensuring that Columbia Care maintains its reputation for quality and consistency in the competitive cannabis industry.

Kathleen Rithisorn, the Managing Director at Columbia Care, oversees strategic investment initiatives and capital deployment for the organization. Managing Director Rithisorn evaluates market opportunities to enhance the company's footprint in the medical cannabis sector. This role involves coordinating with executive leadership to optimize asset performance and drive revenue growth across various state-level operations. By analyzing industry trends and competitive dynamics, the Managing Director ensures that Columbia Care maintains a robust portfolio of high-value assets. Kathleen Rithisorn also facilitates communication between internal departments and external stakeholders to streamline business development efforts. Through rigorous financial modeling and risk assessment, Rithisorn supports the company's commitment to delivering consistent value. The Managing Director focuses on scaling operations efficiently while maintaining the high standards required for pharmaceutical-grade production. Strategic oversight provided by Rithisorn remains vital for long-term stability and market competitiveness.